Immunotherapy biomarkers 2016

Overcoming the barriers

James L. Gulley, Jay A. Berzofsky, Marcus O. Butler, Alessandra Cesano, Bernard A. Fox, Sacha Gnjatic, Sylvia Janetzki, Shyam Kalavar, Vaios Karanikas, Samir N. Khleif, Ilan Kirsch, Peter P. Lee, Cristina Maccalli, Holden Maecker, Jeffrey Schlom, Barbara Seliger, Janet Siebert, David F. Stroncek, Magdalena Thurin, Jianda Yuan & 1 others Lisa H. Butterfield

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

This report summarizes the symposium, 'Immunotherapy Biomarkers 2016: Overcoming the Barriers', which was held on April 1, 2016 at the National Institutes of Health in Bethesda, Maryland. The symposium, cosponsored by the Society for Immunotherapy of Cancer (SITC) and the National Cancer Institute (NCI), focused on emerging immunotherapy biomarkers, new technologies, current hurdles to further progress, and recommendations for advancing the field of biomarker development.

Original languageEnglish (US)
Article number29
JournalJournal for ImmunoTherapy of Cancer
Volume5
Issue number1
DOIs
StatePublished - Mar 21 2017

Fingerprint

Immunotherapy
Biomarkers
National Cancer Institute (U.S.)
National Institutes of Health (U.S.)
Technology
Neoplasms

Keywords

  • Baseline measures
  • Biomarkers
  • High throughput
  • Immune monitoring
  • Immunotherapy
  • Tumor microenvironment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Gulley, J. L., Berzofsky, J. A., Butler, M. O., Cesano, A., Fox, B. A., Gnjatic, S., ... Butterfield, L. H. (2017). Immunotherapy biomarkers 2016: Overcoming the barriers. Journal for ImmunoTherapy of Cancer, 5(1), [29]. https://doi.org/10.1186/s40425-017-0225-6

Immunotherapy biomarkers 2016 : Overcoming the barriers. / Gulley, James L.; Berzofsky, Jay A.; Butler, Marcus O.; Cesano, Alessandra; Fox, Bernard A.; Gnjatic, Sacha; Janetzki, Sylvia; Kalavar, Shyam; Karanikas, Vaios; Khleif, Samir N.; Kirsch, Ilan; Lee, Peter P.; Maccalli, Cristina; Maecker, Holden; Schlom, Jeffrey; Seliger, Barbara; Siebert, Janet; Stroncek, David F.; Thurin, Magdalena; Yuan, Jianda; Butterfield, Lisa H.

In: Journal for ImmunoTherapy of Cancer, Vol. 5, No. 1, 29, 21.03.2017.

Research output: Contribution to journalArticle

Gulley, JL, Berzofsky, JA, Butler, MO, Cesano, A, Fox, BA, Gnjatic, S, Janetzki, S, Kalavar, S, Karanikas, V, Khleif, SN, Kirsch, I, Lee, PP, Maccalli, C, Maecker, H, Schlom, J, Seliger, B, Siebert, J, Stroncek, DF, Thurin, M, Yuan, J & Butterfield, LH 2017, 'Immunotherapy biomarkers 2016: Overcoming the barriers', Journal for ImmunoTherapy of Cancer, vol. 5, no. 1, 29. https://doi.org/10.1186/s40425-017-0225-6
Gulley JL, Berzofsky JA, Butler MO, Cesano A, Fox BA, Gnjatic S et al. Immunotherapy biomarkers 2016: Overcoming the barriers. Journal for ImmunoTherapy of Cancer. 2017 Mar 21;5(1). 29. https://doi.org/10.1186/s40425-017-0225-6
Gulley, James L. ; Berzofsky, Jay A. ; Butler, Marcus O. ; Cesano, Alessandra ; Fox, Bernard A. ; Gnjatic, Sacha ; Janetzki, Sylvia ; Kalavar, Shyam ; Karanikas, Vaios ; Khleif, Samir N. ; Kirsch, Ilan ; Lee, Peter P. ; Maccalli, Cristina ; Maecker, Holden ; Schlom, Jeffrey ; Seliger, Barbara ; Siebert, Janet ; Stroncek, David F. ; Thurin, Magdalena ; Yuan, Jianda ; Butterfield, Lisa H. / Immunotherapy biomarkers 2016 : Overcoming the barriers. In: Journal for ImmunoTherapy of Cancer. 2017 ; Vol. 5, No. 1.
@article{aa303d227da846e683f5057a74410772,
title = "Immunotherapy biomarkers 2016: Overcoming the barriers",
abstract = "This report summarizes the symposium, 'Immunotherapy Biomarkers 2016: Overcoming the Barriers', which was held on April 1, 2016 at the National Institutes of Health in Bethesda, Maryland. The symposium, cosponsored by the Society for Immunotherapy of Cancer (SITC) and the National Cancer Institute (NCI), focused on emerging immunotherapy biomarkers, new technologies, current hurdles to further progress, and recommendations for advancing the field of biomarker development.",
keywords = "Baseline measures, Biomarkers, High throughput, Immune monitoring, Immunotherapy, Tumor microenvironment",
author = "Gulley, {James L.} and Berzofsky, {Jay A.} and Butler, {Marcus O.} and Alessandra Cesano and Fox, {Bernard A.} and Sacha Gnjatic and Sylvia Janetzki and Shyam Kalavar and Vaios Karanikas and Khleif, {Samir N.} and Ilan Kirsch and Lee, {Peter P.} and Cristina Maccalli and Holden Maecker and Jeffrey Schlom and Barbara Seliger and Janet Siebert and Stroncek, {David F.} and Magdalena Thurin and Jianda Yuan and Butterfield, {Lisa H.}",
year = "2017",
month = "3",
day = "21",
doi = "10.1186/s40425-017-0225-6",
language = "English (US)",
volume = "5",
journal = "Journal for ImmunoTherapy of Cancer",
issn = "2051-1426",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Immunotherapy biomarkers 2016

T2 - Overcoming the barriers

AU - Gulley, James L.

AU - Berzofsky, Jay A.

AU - Butler, Marcus O.

AU - Cesano, Alessandra

AU - Fox, Bernard A.

AU - Gnjatic, Sacha

AU - Janetzki, Sylvia

AU - Kalavar, Shyam

AU - Karanikas, Vaios

AU - Khleif, Samir N.

AU - Kirsch, Ilan

AU - Lee, Peter P.

AU - Maccalli, Cristina

AU - Maecker, Holden

AU - Schlom, Jeffrey

AU - Seliger, Barbara

AU - Siebert, Janet

AU - Stroncek, David F.

AU - Thurin, Magdalena

AU - Yuan, Jianda

AU - Butterfield, Lisa H.

PY - 2017/3/21

Y1 - 2017/3/21

N2 - This report summarizes the symposium, 'Immunotherapy Biomarkers 2016: Overcoming the Barriers', which was held on April 1, 2016 at the National Institutes of Health in Bethesda, Maryland. The symposium, cosponsored by the Society for Immunotherapy of Cancer (SITC) and the National Cancer Institute (NCI), focused on emerging immunotherapy biomarkers, new technologies, current hurdles to further progress, and recommendations for advancing the field of biomarker development.

AB - This report summarizes the symposium, 'Immunotherapy Biomarkers 2016: Overcoming the Barriers', which was held on April 1, 2016 at the National Institutes of Health in Bethesda, Maryland. The symposium, cosponsored by the Society for Immunotherapy of Cancer (SITC) and the National Cancer Institute (NCI), focused on emerging immunotherapy biomarkers, new technologies, current hurdles to further progress, and recommendations for advancing the field of biomarker development.

KW - Baseline measures

KW - Biomarkers

KW - High throughput

KW - Immune monitoring

KW - Immunotherapy

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85015670865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015670865&partnerID=8YFLogxK

U2 - 10.1186/s40425-017-0225-6

DO - 10.1186/s40425-017-0225-6

M3 - Article

VL - 5

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

SN - 2051-1426

IS - 1

M1 - 29

ER -